Trevi is a clinical-stage biopharma company currently developing the investigational oral therapy Haduvio™ (nalbuphine ER) for serious chronic cough conditions.

ID: 356229474

linkhttp://www.trevitherapeutics.com calendar_today16-08-2011 14:54:03